|
Real-time Estimate
Cboe BZX
12:31:31 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 44.42 USD | -0.86% |
|
-2.88% | +232.34% |
| Market Cap | 6.02B 5.16B 4.83B 4.42B 8.33B 574B 8.42B 57.02B 22.2B 290B 22.61B 22.12B 959B | P/E 2026 * |
-14.2x | P/E 2027 * | -22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.97B 4.25B 3.99B 3.64B 6.87B 473B 6.94B 47.03B 18.31B 239B 18.64B 18.24B 791B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 165x |
| Free-Float |
98.27% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Definium Therapeutics, Inc.
| 1 day | -0.86% | ||
| 1 week | -2.88% | ||
| Current month | +2.25% | ||
| 1 month | +4.34% | ||
| 3 months | +94.49% | ||
| 6 months | +157.37% | ||
| Current year | +232.34% |
| 1 week | 41.25 |  | 46.57 |
| 1 month | 40.29 | | 49.7 |
| Current year | 12.88 | | 49.7 |
| 1 year | 8.7 | | 49.7 |
| 3 years | 2.41 | | 49.7 |
| 5 years | 2.12 | | 49.7 |
| 10 years | 1.25 | | 86.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | 37 | 2021-06-08 |
Brandi Roberts
DFI | Director of Finance/CFO | 52 | 2025-06-01 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 46 | 2021-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Barrow
BRD | Director/Board Member | 37 | 2021-12-12 |
Andreas Krebs
BRD | Director/Board Member | 67 | 2021-09-28 |
Carol Vallone
CHM | Chairman | 69 | 2021-12-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/12/26 | Free | Chief Financial Officer | 62,500 | 0.0471% | ||
| 8/12/26 | Free | General Counsel | 62,500 | 0.0471% | ||
| 8/12/26 | Free | Chief Technology Officer | 100,000 | 0.0753% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -2.88% | +345.45% | +1,067.98% | 6.02B | |
| -1.01% | +1.48% | +1.66% | +23.62% | 51.65B | |
| +0.21% | -0.93% | +470.54% | +559.24% | 45.31B | |
| +0.73% | +5.04% | +39.46% | +18.06% | 42.7B | |
| -0.38% | -0.37% | +21.54% | +85.79% | 42.79B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 32.87B | |
| +0.75% | +1.66% | +31.77% | +136.33% | 17.14B | |
| -0.84% | -3.22% | - | - | 16.61B | |
| -1.70% | +3.06% | +11.11% | +28.57% | 15.01B | |
| +0.06% | +2.78% | +82.07% | +49.96% | 14.21B | |
| Average | -0.53% | +2.38% | +113.09% | +224.56% | 28.43B | |
| Weighted average by Cap. | -0.46% | +2.62% | +106.22% | +159.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 31.42M 26.92M 25.23M 23.04M 43.49M 3B 43.92M 298M 116M 1.51B 118M 115M 5B |
| Net income | -376M -322M -302M -276M -521M -35.85B -526M -3.56B -1.39B -18.09B -1.41B -1.38B -59.91B | -273M -234M -219M -200M -378M -26.03B -382M -2.59B -1.01B -13.13B -1.03B -1B -43.5B |
| Net Debt | -1.06B -905M -848M -774M -1.46B -101B -1.48B -10B -3.89B -50.78B -3.96B -3.88B -168B | -845M -724M -679M -620M -1.17B -80.56B -1.18B -8B -3.12B -40.65B -3.17B -3.1B -135B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | US$44.50 | -0.69% | 632,180 |
| 26-08-25 | US$44.81 | +3.56% | 1,271,071 |
| 26-08-24 | US$43.27 | -3.65% | 1,727,347 |
| 26-08-21 | US$44.91 | -1.08% | 1,355,409 |
| 26-08-20 | US$45.40 | -0.92% | 1,661,766 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DFTX Stock
Select your edition
All financial news and data tailored to specific country editions
